CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

How Digital Transformation Has Impacted Patient Recruiting and Engagement Initiatives

How Digital Transformation Has...

The Need for Digital Shift in Patient Recruitment and Engagement

The Need for Digital Shift in Patient...

Clinically Media's Ceo Named One Of The Most Influential People In Healthcare Today

Clinically Media's Ceo Named One Of...

How to Use Clinical Trial Matching Software for The Trials?

How to Use Clinical Trial Matching...

Advanced HPV-16 Positive Head and Neck Cancer: PDS Biotech Enlists First Stage of Checkpoint Inhibitor Nave Patients

Advanced HPV-16 Positive Head and...

StudyKIK Acquired by Syneos Health to Deliver Patient and Physician Benefits

StudyKIK Acquired by Syneos Health to...

Syneos Health Partners with Ride Health

Syneos Health Partners with Ride Health

How Patient Recruitment Technologies Can Enhance Clinical Trials

How Patient Recruitment Technologies...

How Digital Transformation Has Impacted Patient Recruiting and Engagement Initiatives

How Digital Transformation Has...

The Need for Digital Shift in Patient Recruitment and Engagement

The Need for Digital Shift in Patient...

Patient Recruitment: Market and Strategies

Life Sciences Review | Thursday, September 09, 2021
Tweet

Depending on the drug's therapeutic area, the total cost associated with all phases of a clinical study might range from 44 million dollars to 115.3 million dollars, according to a report.


FREMONT, CA: If a clinical trial's clinical research team fails to enroll enough study volunteers, the study's timeframe will be extended by default, increasing resource utilization and expenditures. A prolonged study start may cause a drug or treatment to take longer to reach the market, extending both the time and the public's access to it.


Clinical Trial Market


The clinical trial market is massive and fast expanding. Clinicaltrials.gov began with 2,119 active studies in the year 2000 and today has over 280,000 ongoing clinical research projects. This means that the market is increasing in value, with a projected value of 65.2 billion dollars by 2025. Depending on the drug's therapeutic area, the total cost associated with all phases of a clinical study might range from 44 million dollars to 115.3 million dollars, according to a report. Moreover, only one out of every ten medications that undergo clinical trials makes it to market.


Statistics of Patient Recruitment Failures


Along with the growing clinical trial market, there are also significant barriers to patient recruiting. Here are some stats to consider. More than 80 percent of clinical trials in the United States fail to achieve their patient recruiting deadlines, according to the National Institutes of Health (NIH).


These delays raise prices, deplete resources, and lengthen its time to get into the market.



  • Eighty-six percent of clinical trials fail to meet their recruiting goals within the time frame allotted.

  • According to an examination of registered trials, 19 percent of trials were discontinued or terminated early due to insufficient participants.

  • According to the FDA, only 6 percent of clinical studies are finished on time, and 80 percent of trials are delayed by at least one month due to unfilled enrollment.


Strategies to Improve Patient Recruitment


There are many theories and suggestions for improving patient recruitment; however, none of them are foolproof and vary depending on the trial. These, on the other hand, may help to improve the situation to some amount.



  • The feasibility of conducting a clinical trial.

  • Creating the ideal patient-to-stakeholder connection approach.

  • Clinical trial protocol designs that are centered on the patient.

  • Using cutting-edge technology and digital trends. Having a thorough awareness of the regulatory requirements is essential.


See Also: Top Life Science Compliance Solution Companies


Weekly Brief

loading
> <
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue

Read Also

Role of Predictive Genomics in Sustainable Healthcare

Role of Predictive Genomics in Sustainable Healthcare

A Conversational AI Approach to Regulatory Intelligence

A Conversational AI Approach to Regulatory Intelligence

A rise in DNA Sequencing Market is expected in coming years

A rise in DNA Sequencing Market is expected in coming years

Omniabio Inc. Announces Private Investor

Omniabio Inc. Announces Private Investor
Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Data analysis for next-generation sequencing worth USD1.2 billion by 2026 - Cloud-based platforms emerging as preferred solutions

Lithuania's Vision to Become a Biotech Hub in Europe

Lithuania's Vision to Become a Biotech Hub in Europe

Bridging the Diversity Gap in Genomics

Bridging the Diversity Gap in Genomics

How does Biotechnology Provide Solutions to Human Needs?

How does Biotechnology Provide Solutions to Human Needs?
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/patient-recruitment-market-and-strategies--nwid-549.html